FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation

PMA: P220032 · Supplement: S007 · Decision Aug 23, 2024
Classifications
1
FEI Numbers
61
Registration Numbers
61

Basic Information

Device Name
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation
Trade Name
POLARx FIT Cryoablation Balloon Catheters
PMA Number
P220032
Supplement Number
S007
Device Class
FDA Class 3
Product Code
OAE
Generic Name
Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
August 23, 2024
Date Received
July 26, 2024
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

the addition of a visual inspection step to identify an issue related to field reports of high pressure error messages

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OAE Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation